ACAAI Network Search

Complete the 2026 Provider Compensation Survey and find out how your compensation compared to other allergists during 2025.… The College is thrilled to partner with the Medical Group Management Association (MGMA) for the tenth consecutive year to collect allergy-specific compensation and practice financial data!…

The Advocacy Council received a query on "Can I bill Medicare for negative and positive (histamine) controls for allergy… The Advocacy Council regularly receives queries from members on how to correctly code specific scenarios. Recently we received a request asking: Question: Can I bill…

Please note, this promotion is not available through the society store and can only be redeemed via the regular UpToDate… Many College members enjoy the discounted subscription to UpToDate®, the clinical decision support resource that medical trainees and physicians trust for reliable clinical answers. Our…

The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new… Last December the Trump administration unveiled two proposed rules designed to curb rising drug costs under Medicare Parts B and D, extending the Most Favored…

Compounding guidelines ensure patient safety by minimizing contamination, incorrect dosing, or other errors during sterile preparation.… Physicians who mix allergy immunotherapy injections in their offices must still comply with USP 797 standards to remain in full compliance with state and federal regulations. These pharmaceutical…

This article outlines important payment and policy changes that will shape reimbursement and practice operations for allergists in the coming… On Nov. 5, 2025, CMS released a final rule updating the Medicare Physician Fee Schedule for 2026. This article outlines important payment and policy…

Always verify individual payer policies in writing before initiating OIT services, as coverage and accepted codes vary widely.… Inquiries regarding the use of CPT 95180 (rapid desensitization procedure) for food oral immunotherapy (OIT), including peanut OIT (Palforzia®) and food-based protocols, have recently been submitted…

This issue began appearing last fall, affecting multiple Medicare Administrative Contractors (MACs). Denials typically cite reason code CO-50.… Recent changes associated with the implementation of new Local Coverage Determinations (LCDs) and billing articles for allergen immunotherapy have inadvertently led to systematic denials of claims…

The cornerstone of effective food allergy diagnosis is a thorough clinical history.… Common queries on food allergy testing As we wrap up another year of groundbreaking advances in allergy and immunology, the College has noted a surge in inquiries from fellow allergists about food…

Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts… The College has recently been alerted to an ongoing prior authorization policy implemented by the Blue Cross Blue Shield Federal Employee Program (FEP) for…

These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.… Allergists are seeing a growing number of claim denials for CPT code 95165 - professional services for supervising the preparation and provision of antigens for allergen immunotherapy -…

All seven MACs have now agreed in writing to cover the build-up phase of allergy extract preparation and administration.… To understand Medicare coverage for allergy immunotherapy, it is important to clarify the distinction between the build-up phase and dilutions of allergy extracts, as well…

These strategies by payers create administrative burdens that divert allergists' resources to administrative tasks instead of patient care.… Changes are coming to Cigna’s code review policy practices, and these changes will impact allergists. Cigna Healthcare will begin downcoding certain high-level evaluation and management (E/M)…

We continue to encourage physicians and medical groups to voice their concerns until Cigna’s the policy is formally withdrawn.… Due to a lack of transparency, medical organizations are unclear if the recently announced CIGNA pause on downcoding applies to California only or to the…

The following are some of the key actions taken by the ACAAI Board of Regents and Executive Committee at recent… The following are some of the key actions taken by the ACAAI Board of Regents and Executive Committee at recent meetings. Ratified the decision…

The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.… State and federal advocacy have been at the core of the College for more than 50 years. What began with the Joint Council of Allergy, Asthma…

The Training Program Directors Committee oversees the College’s SPARK Program, a vital effort to cultivate new physicians for our… The Training Program Directors (TPD) Committee oversees the College’s SPARK Program, a vital effort to cultivate a pipeline of new physicians for our specialty. The…

ACAAI Executive Medical Director Dr. Todd Mahr shares his thoughts on the role of committees in our strategic planning… As the College develops its 2027 – 2029 strategic plan, committee input is vital. ACAAI Executive Medical Director Dr. Todd Mahr shares his thoughts on…

The College is developing its next three year strategic plan, which will guide our work from 2027 through 2029.… The College is developing its next three‑year strategic plan, which will guide our work from 2027 through 2029. This plan will serve as a roadmap…

For the first time, large scale AI platforms are being built explicitly for health care delivery rather than adapted from… By: Fatima Khan, MD, FACAAI, Chair of AI and Technology Subcommittee The past few months have marked a turning point in the evolution of…